Frankfurt - Delayed Quote EUR
Egetis Therapeutics AB (publ) (P0F.F)
0.3125
-0.0035
(-1.11%)
As of 9:17:19 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 5 |
| Avg. Estimate | 18M | 25M | 95.02M | 401.73M |
| Low Estimate | 18M | 25M | 90.13M | 228.82M |
| High Estimate | 18M | 25M | 99.9M | 562.4M |
| Year Ago Sales | 13.9M | 9.4M | 46.1M | 95.02M |
| Sales Growth (year/est) | 29.50% | 165.96% | 106.11% | 322.81% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| P0F.F | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Related Tickers
PRQR ProQR Therapeutics N.V.
1.7800
0.00%
WVE Wave Life Sciences Ltd.
6.50
+4.00%
ZLAB Zai Lab Limited
31.13
-0.19%
LXEO Lexeo Therapeutics, Inc.
2.8200
+3.68%
IMVT Immunovant, Inc.
15.44
+0.19%
QURE uniQure N.V.
15.16
+4.66%
ROIV Roivant Sciences Ltd.
11.25
+0.67%
TSHA Taysha Gene Therapies, Inc.
2.7800
-0.18%
RCKT Rocket Pharmaceuticals, Inc.
2.9600
+6.86%
MRUS Merus N.V.
62.42
+6.65%